Atrium Therapeutics, Inc. (RNA) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time RNA price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 48.4 Neutral
Market Cap $208.2M
Volume 68.0K
Fundamentals — 10-Q Q1 2026
Revenue $19.6M
Net Income $-16.6M
EPS $-0.97
Operating Margin -88.0%
Net Margin -84.7%
P/E Ratio -12.5x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Hughes Steven George | Chief Medical Officer | Sell | 2,209 | $47.54 | $105,016 | 2025 Oct 22 |
| McCarthy Teresa | Chief Human Resources Officer | Sell | 20,000 | $50.15 | $1.0M | 2025 Oct 15 |
| Mosbrooker Eric | Chief Commercial Officer | Sell | 6,562 | $45.38 | $297,784 | 2025 Oct 3 |
| Hughes Steven George | Chief Medical Officer | Sell | 2,208 | $40.58 | $89,601 | 2025 Sep 22 |
| McCarthy Teresa | Chief Human Resources Officer | Sell | 15,000 | $41.41 | $621,150 | 2025 Sep 15 |
| Hughes Steven George | Chief Medical Officer | Sell | 1,542 | $45.41 | $70,022 | 2025 Sep 15 |
| Flanagan W. Michael | Chief Scientific Officer | Sell | 20,000 | $38.94 | $778,800 | 2025 Sep 11 |
| Wilson Troy Edward | Director | Sell | 29,500 | $50.00 | $1.5M | 2025 Sep 5 |
| Boyce Sarah | President and CEO | Sell | 50,000 | $49.95 | $2.5M | 2025 Sep 5 |
| Mosbrooker Eric | Chief Commercial Officer | Sell | 6,563 | $47.07 | $308,920 | 2025 Sep 3 |
| Gallagher Kathleen P. | Chief Program Officer | Sell | 188 | $47.42 | $8,915 | 2025 Sep 2 |
| Boyce Sarah | President and CEO | Sell | 25,000 | $49.39 | $1.2M | 2025 Aug 28 |
| Hughes Steven George | Chief Medical Officer | Sell | 2,208 | $46.40 | $102,451 | 2025 Aug 22 |
| McCarthy Teresa | Chief Human Resources Officer | Sell | 10,000 | $46.56 | $465,600 | 2025 Aug 15 |
| Hughes Steven George | Chief Medical Officer | Sell | 1,542 | $46.66 | $71,950 | 2025 Aug 13 |
| MacLean Michael F | Chief Financial Officer | Sell | 30,914 | $42.73 | $1.3M | 2025 Aug 6 |
| Mosbrooker Eric | Chief Commercial Officer | Sell | 130,807 | $44.06 | $5.8M | 2025 Aug 6 |
| Hughes Steven George | Chief Medical Officer | Sell | 81,434 | $42.74 | $3.5M | 2025 Aug 6 |
| Levin Arthur A | Director | Sell | 107,500 | $47.62 | $5.1M | 2025 Aug 6 |
| Wilson Troy Edward | Director | Sell | 95,054 | $45.00 | $4.3M | 2025 Aug 6 |
Other Pharmaceutical Stocks
- LLY Eli Lilly and Company
- JNJ Johnson & Johnson
- ABBV AbbVie Inc.
- IFRX InflaRx N.V.
- ADAG Adagene Inc. - ADS, each representing 1.25 ordinary shares
- TLX Telix Pharmaceuticals Limited - American Depositary Shares
- PHAR Pharming Group N.V. - ADS, each representing 10 ordinary shares
- BTAI BioXcel Therapeutics, Inc.
Take RNA further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put RNA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Atrium Therapeutics, Inc. next reports.
Set alerts on RNA
Get notified when Atrium Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free